AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Vaccine

Results: 51-75/3357

Authors: Jansen, WTM Verheul, AFM Veeneman, GH van Boom, JH Snippe, H
Citation: Wtm. Jansen et al., Revised interpretation of the immunological results obtained with pneumococcal polysaccharide 17F derived synthetic di-, tri- and tetrasaccharide conjugates in mice and rabbits, VACCINE, 20(1-2), 2001, pp. 19-21

Authors: Dhiman, N Bonilla, R O'Kane, D Poland, GA
Citation: N. Dhiman et al., Gene expression microarrays: a 21st century tool for directed vaccine design, VACCINE, 20(1-2), 2001, pp. 22-30

Authors: Robertson, SE Mayans, MV El-Husseiny, A Clemens, JD Ivanoff, B
Citation: Se. Robertson et al., The WHO vaccine trial registry, VACCINE, 20(1-2), 2001, pp. 31-41

Authors: Liu, LJ Watabe, S Yang, J Hamajima, K Ishii, N Hagiwara, E Onari, K Xin, KQ Okuda, K
Citation: Lj. Liu et al., Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses, VACCINE, 20(1-2), 2001, pp. 42-48

Authors: Finerty, S Stokes, CR Gruffydd-Jones, TJ Hillman, TJ Barr, FJ Harbour, DA
Citation: S. Finerty et al., Targeted lymph node immunization can protect cats from a mucosal challengewith feline immunodeficiency virus, VACCINE, 20(1-2), 2001, pp. 49-58

Authors: Ghosh, A Zhang, WW Matlashewski, G
Citation: A. Ghosh et al., Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections, VACCINE, 20(1-2), 2001, pp. 59-66

Authors: Matheis, W Zott, A Schwanig, M
Citation: W. Matheis et al., The role of the adsorption process for production and control combined adsorbed vaccines, VACCINE, 20(1-2), 2001, pp. 67-73

Authors: Atti, MLC Salmaso, S Cotter, B Gallo, G Alfarone, G Pinto, A Bella, A von Hunolstein, C
Citation: Mlc. Atti et al., Reactogenicity and immunogenicity of adult versus paediatric diphtheria and tetanus booster dose at 6 years of age, VACCINE, 20(1-2), 2001, pp. 74-79

Authors: Shi, Y HogenEsch, H Hem, SL
Citation: Y. Shi et al., Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines, VACCINE, 20(1-2), 2001, pp. 80-85

Authors: Dewulf, J Leavens, H Koenen, F Mintiens, K de Kruif, A
Citation: J. Dewulf et al., An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus, VACCINE, 20(1-2), 2001, pp. 86-91

Authors: Madalinski, K Sylvan, SPE Hellstrom, U Mikolajewicz, J Zembrzuska-Sadkowska, E Piontek, E
Citation: K. Madalinski et al., Antibody responses to preS components after immunization of children with low doses of BioHepB, VACCINE, 20(1-2), 2001, pp. 92-97

Authors: Inagaki-Ohara, K Iwasaki, T Watanabe, D Kurata, T Nishiyama, Y
Citation: K. Inagaki-ohara et al., Effect of the deletion of US2 and US3 from herpes simplex virus type 2 on immune responses in the murine vagina following intravaginal infection, VACCINE, 20(1-2), 2001, pp. 98-104

Authors: Nagata, T Higashi, T Aoshi, T Suzuki, M Uchijima, M Koide, Y
Citation: T. Nagata et al., Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization, VACCINE, 20(1-2), 2001, pp. 105-114

Authors: Moore, RJ Lenghaus, C Sheedy, SA Doran, TJ
Citation: Rj. Moore et al., Improved vectors for expression library immunization - application to Mycoplasma hyopneumoniae infection in pigs, VACCINE, 20(1-2), 2001, pp. 115-120

Authors: Wutzler, P Farber, I Wagenpfeil, S Bisanz, H Tischer, A
Citation: P. Wutzler et al., Seroprevalence of varicella-zoster virus in the German population, VACCINE, 20(1-2), 2001, pp. 121-124

Authors: Saito, T Lim, W Suzuki, T Suzuki, Y Kida, H Nishimura, SI Tashiro, M
Citation: T. Saito et al., Characterization of a human H9N2 influenza virus isolated in Hong Kong, VACCINE, 20(1-2), 2001, pp. 125-133

Authors: Yura, M Takahashi, I Terawaki, S Hiroi, T Kweon, MN Yuki, Y Kiyono, H
Citation: M. Yura et al., Nasal administration of cholera toxin (CT) suppresses clinical signs of experimental autoimmune encephalomyelitis (EAE), VACCINE, 20(1-2), 2001, pp. 134-139

Authors: Zheng, BJ Woo, PCY Ng, MH Tsoi, HW Wong, LP Yuen, KY
Citation: Bj. Zheng et al., A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model, VACCINE, 20(1-2), 2001, pp. 140-147

Authors: Li, WM Bally, MB Schutze-Redelmeier, MP
Citation: Wm. Li et al., Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes, VACCINE, 20(1-2), 2001, pp. 148-157

Authors: Rimmelzwaan, GF Baars, M van Amerongen, G van Beek, R Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses, VACCINE, 20(1-2), 2001, pp. 158-163

Authors: Hedlund, J Langer, B Konradsen, HB Ortqvist, A
Citation: J. Hedlund et al., Negligible adjuvant effect for antibody responses and frequent adverse events associated with IL-12 treatment in humans vaccinated with pneumococcal polysaccharide, VACCINE, 20(1-2), 2001, pp. 164-169

Authors: Mauch, C Grimm, C Meckel, S Wands, JR Blum, HE Roggendorf, A Geissler, M
Citation: C. Mauch et al., Induction of cytotoxic T lymphocyte responses against hepatitis delta virus antigens which protect against tumor formation in mice, VACCINE, 20(1-2), 2001, pp. 170-180

Authors: Straubinger, RK Rao, TD Davidson, E Summers, BA Jacobson, RH Frey, AB
Citation: Rk. Straubinger et al., Protection against tick-transmitted Lyme disease in dogs vaccinated with amultiantigenic vaccine, VACCINE, 20(1-2), 2001, pp. 181-193

Authors: Nurkka, A Ahman, H Yaich, M Eskola, J Kayhty, H
Citation: A. Nurkka et al., Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT, VACCINE, 20(1-2), 2001, pp. 194-201

Authors: Bos, JM Rumke, HC Welte, R Postma, MJ Jager, JC
Citation: Jm. Bos et al., Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program, VACCINE, 20(1-2), 2001, pp. 202-207
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>